| Marissa Jacobs, DO | |
|
19389 N 59th Ave, Glendale, AZ 85308-6500 | |
| (623) 537-6000 | |
| (623) 537-6014 |
| Full Name | Marissa Jacobs |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 19389 N 59th Ave, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821522632 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 007754 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwestern University | 6305734773 | 112 |
News Archive
The West African nation of Burkina Faso today became the first country to begin a nationwide campaign to introduce a new meningitis vaccine that promises to rid the entire region of the primary cause of epidemic meningitis. The first vaccine designed specifically for Africa, MenAfriVac is expected to help health workers eliminate meningococcal A epidemics in the 25 countries of the meningitis belt, stretching from Senegal in the west to Ethiopia in the east.
Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today launched a new custom dose feature in Europe and Canada for TheraSphere, Nordion's Y-90 microsphere treatment for liver cancer.
People who have experienced a heart attack (myocardial infarction), stroke or cardiac arrest are significantly less likely to be working than healthy people, and if they are working, on average have lower incomes, found a study published in CMAJ.
MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has achieved a significant scientific milestone by publishing three manuscripts in Nature Immunology that advance the understanding of the immune system and highlight underlying mechanisms in two little-understood disease areas - chronic obstructive pulmonary disease (COPD) and systemic lupus erythematosus (SLE).
› Verified 2 days ago
| Entity Name | Midwestern University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932206414 PECOS PAC ID: 6305734773 Enrollment ID: O20040308000663 |
News Archive
The West African nation of Burkina Faso today became the first country to begin a nationwide campaign to introduce a new meningitis vaccine that promises to rid the entire region of the primary cause of epidemic meningitis. The first vaccine designed specifically for Africa, MenAfriVac is expected to help health workers eliminate meningococcal A epidemics in the 25 countries of the meningitis belt, stretching from Senegal in the west to Ethiopia in the east.
Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today launched a new custom dose feature in Europe and Canada for TheraSphere, Nordion's Y-90 microsphere treatment for liver cancer.
People who have experienced a heart attack (myocardial infarction), stroke or cardiac arrest are significantly less likely to be working than healthy people, and if they are working, on average have lower incomes, found a study published in CMAJ.
MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has achieved a significant scientific milestone by publishing three manuscripts in Nature Immunology that advance the understanding of the immune system and highlight underlying mechanisms in two little-understood disease areas - chronic obstructive pulmonary disease (COPD) and systemic lupus erythematosus (SLE).
› Verified 2 days ago
| Entity Name | Honorhealth Urgent Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740273614 PECOS PAC ID: 0345130266 Enrollment ID: O20040316000867 |
News Archive
The West African nation of Burkina Faso today became the first country to begin a nationwide campaign to introduce a new meningitis vaccine that promises to rid the entire region of the primary cause of epidemic meningitis. The first vaccine designed specifically for Africa, MenAfriVac is expected to help health workers eliminate meningococcal A epidemics in the 25 countries of the meningitis belt, stretching from Senegal in the west to Ethiopia in the east.
Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today launched a new custom dose feature in Europe and Canada for TheraSphere, Nordion's Y-90 microsphere treatment for liver cancer.
People who have experienced a heart attack (myocardial infarction), stroke or cardiac arrest are significantly less likely to be working than healthy people, and if they are working, on average have lower incomes, found a study published in CMAJ.
MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has achieved a significant scientific milestone by publishing three manuscripts in Nature Immunology that advance the understanding of the immune system and highlight underlying mechanisms in two little-understood disease areas - chronic obstructive pulmonary disease (COPD) and systemic lupus erythematosus (SLE).
› Verified 2 days ago
| Entity Name | Neighborhood Outreach Access To Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942518550 PECOS PAC ID: 3577743764 Enrollment ID: O20110204000504 |
News Archive
The West African nation of Burkina Faso today became the first country to begin a nationwide campaign to introduce a new meningitis vaccine that promises to rid the entire region of the primary cause of epidemic meningitis. The first vaccine designed specifically for Africa, MenAfriVac is expected to help health workers eliminate meningococcal A epidemics in the 25 countries of the meningitis belt, stretching from Senegal in the west to Ethiopia in the east.
Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today launched a new custom dose feature in Europe and Canada for TheraSphere, Nordion's Y-90 microsphere treatment for liver cancer.
People who have experienced a heart attack (myocardial infarction), stroke or cardiac arrest are significantly less likely to be working than healthy people, and if they are working, on average have lower incomes, found a study published in CMAJ.
MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has achieved a significant scientific milestone by publishing three manuscripts in Nature Immunology that advance the understanding of the immune system and highlight underlying mechanisms in two little-understood disease areas - chronic obstructive pulmonary disease (COPD) and systemic lupus erythematosus (SLE).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marissa Jacobs, DO 19389 N 59th Ave, Glendale, AZ 85308-6500 Ph: (623) 537-6000 | Marissa Jacobs, DO 19389 N 59th Ave, Glendale, AZ 85308-6500 Ph: (623) 537-6000 |
News Archive
The West African nation of Burkina Faso today became the first country to begin a nationwide campaign to introduce a new meningitis vaccine that promises to rid the entire region of the primary cause of epidemic meningitis. The first vaccine designed specifically for Africa, MenAfriVac is expected to help health workers eliminate meningococcal A epidemics in the 25 countries of the meningitis belt, stretching from Senegal in the west to Ethiopia in the east.
Nordion Inc., a leading provider of products and services for the prevention, diagnosis and treatment of disease, today launched a new custom dose feature in Europe and Canada for TheraSphere, Nordion's Y-90 microsphere treatment for liver cancer.
People who have experienced a heart attack (myocardial infarction), stroke or cardiac arrest are significantly less likely to be working than healthy people, and if they are working, on average have lower incomes, found a study published in CMAJ.
MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has achieved a significant scientific milestone by publishing three manuscripts in Nature Immunology that advance the understanding of the immune system and highlight underlying mechanisms in two little-understood disease areas - chronic obstructive pulmonary disease (COPD) and systemic lupus erythematosus (SLE).
› Verified 2 days ago
Jeremy Nebeker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 18275 N 59th Avenue, Bldg K 162, Glendale, AZ 85308 Phone: 602-547-8184 Fax: 602-547-8339 | |
Ashwin Parekh, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 W. Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2632 | |
John Mark Heyer, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10150 N 67th Ave, Suite 101, Glendale, AZ 85302 Phone: 623-561-4547 Fax: 632-412-4995 | |
Ron Rosenwald, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6120 W Bell Rd Ste 110, Glendale, AZ 85308 Phone: 602-978-9053 Fax: 602-443-4570 | |
Mr. Arthur N Miller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5757 W Thunderbird Road, Suite E-155, Glendale, AZ 85306 Phone: 623-247-1081 Fax: 623-247-2962 | |
Danielle L. Barnett-trapp, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 19389 N 59th Ave, Glendale, AZ 85308 Phone: 236-537-6000 Fax: 623-537-6101 | |
Jenna Sangkam, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 19389 N 59th Ave, Glendale, AZ 85308 Phone: 623-537-6000 |